Now in its 55th year, the Queen’s award is widely considered to be one of the most prestigious business awards in the UK and demonstrates outstanding success in innovation and sustainable development.
It is the second time that Endomag has received the royal seal of approval, having also been selected as a recipient of the Queen’s Award for Innovation back in 2018.
Since 2018, Endomag has continued to grow rapidly and has also featured twice on the Sunday Times’ FastTrack100 list of the UK’s fastest growing companies.
This latest honour cements the company’s position as one of the UK’s fastest-growing technology businesses and recognises our vast and ever-growing international presence.
Speaking about Endomag’s recent award win, CEO Eric Mayes commented: “We are extremely proud to win our second Queen’s award – this time recognising our International Trade efforts. Since launching our products in the UK, we have established an impressive trading footprint and have continued to enter new markets in Europe, Asia and Australasia.
“Our medical device technologies have so far been able to help over 130,000 women in over 40 countries. Receiving this award is a tremendous achievement and will add to the momentum of the company’s growth as it reinforces our commitment to making a difference for people living with breast cancer”.
Thanks to the Sentimag® platform alongside Magseed® and Magtrace®, hospitals around the world are now able to access a better standard of cancer care. Endomag’s mission is to ensure that this access is made available in every country around the world.